Literature DB >> 16498256

Hepatic encephalopathy: from pathophysiology to treatment.

Antoni Mas1.   

Abstract

Hepatic encephalopathy (HE) is a neuropsychiatric syndrome due to hepatic dysfunction and porto-systemic shunting of the intestinal blood. Cirrhosis is the most frequent liver disease causing HE. On most occasions, HE appears due to a superimposed precipitating factor (gastrointestinal bleeding, infections, renal and electrolyte disturbances, etc.). Ammonia produced in colon by intestinal bacteria is the main toxic substance implicated in the pathogenesis of HE. Other mechanisms, such as changes in the GABA-benzodiazepine system, accumulation of manganese into the basal ganglia of the brain, changes in blood-brain barrier and neurotransmission disturbances are also present. Clinical manifestations of HE may vary widely, from minimal neurologic changes, only detected with specific tests, to deep coma. Treatment of HE should be directed to controlling the precipitating factors, as well as therapies aimed at correcting the above-mentioned pathophysiological changes, mainly reduction of blood ammonia levels. Artificial liver support systems may play a role in the future. Liver transplantation should be evaluated as a definitive therapy in all cases of HE. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16498256     DOI: 10.1159/000089783

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  16 in total

1.  Surgical attenuation of spontaneous congenital portosystemic shunts in dogs resolves hepatic encephalopathy but not hypermanganesemia.

Authors:  Adam G Gow; Polly E Frowde; Clive M Elwood; Carolyn A Burton; Roger M Powell; Simon W Tappin; Rob D Foale; Andrew Duncan; Richard J Mellanby
Journal:  Metab Brain Dis       Date:  2015-05-05       Impact factor: 3.584

2.  Extracellular brain ammonia levels in association with arterial ammonia, intracranial pressure and the use of albumin dialysis devices in pigs with acute liver failure.

Authors:  Kerstin Zwirner; Christian Thiel; Karolin Thiel; Matthias H Morgalla; Alfred Königsrainer; Martin Schenk
Journal:  Metab Brain Dis       Date:  2010-11-18       Impact factor: 3.584

3.  Clinically Evident Portal Hypertension: An Operational Research Definition for Future Investigations in the Pediatric Population.

Authors:  Lee M Bass; Benjamin L Shneider; Lisa Henn; Nathan P Goodrich; John C Magee
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-06       Impact factor: 2.839

4.  Dogs with congenital porto-systemic shunting (cPSS) and hepatic encephalopathy have higher serum concentrations of C-reactive protein than asymptomatic dogs with cPSS.

Authors:  A G Gow; A I Marques; D A Yool; K Crawford; S M Warman; P D Eckersall; R Jalan; R J Mellanby
Journal:  Metab Brain Dis       Date:  2012-02-23       Impact factor: 3.584

Review 5.  Is oral L-acyl-carnitine an effective therapy for hepatic encephalopathy? Review of the literature.

Authors:  Nathan J Shores; Emmet B Keeffe
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

6.  Management of hepatic encephalopathy by traditional chinese medicine.

Authors:  Chun Yao; Nong Tang; Guoxiang Xie; Xiaojiao Zheng; Ping Liu; Lei Fu; Wu Xie; Fan Yao; Houkai Li; Wei Jia
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-05       Impact factor: 2.629

7.  Colectomy for Porto-Systemic Encephalopathy: Is it Still Topical?

Authors:  Rym Ennaifer; Romdhane Hayfa; Rania Hefaiedh; Lobna Marsaoui; Najet Bel Hadj; Tahar Khalfallah
Journal:  Clin Pract       Date:  2013-06-27

8.  Incisional hernia as an unusual cause of hepatic encephalopathy in a 62-year-old man with cirrhosis: a case report.

Authors:  Muge Ustaoglu; Tulay Bakir; Ahmet Bektas; Osman Cure; Bulent Gungor
Journal:  J Med Case Rep       Date:  2009-09-17

9.  Delayed-onset hepatic encephalopathy induced by zolpidem: a case report.

Authors:  Vitor Carlos Santos da Silva; Paulo Lisboa Bittencourt; Sylvania Pinho; Andréa Ribeiro Cavalcanti; Cláudio Celestino Zollinger
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

10.  Association of Proton Pump Inhibitor Therapy with Hepatic Encephalopathy in Hepatitis B Virus-related Acute-on-Chronic Liver Failure.

Authors:  Zhao-Ni Lin; Yong-Qing Zuo; Peng Hu
Journal:  Hepat Mon       Date:  2014-04-07       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.